PLx Pharma Inc.
PLx Pharma Inc. (PLXP) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001497504 · PLXP · NASDAQ · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001497504 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
PLx Pharma Inc. (NASDAQ: PLXP) has submitted 369 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2014. As a Healthcare sector company with CIK 0001497504, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is PLx Pharma Inc.'s most comprehensive regulatory disclosure. The most recent PLx Pharma Inc. 10-K was filed on 2022-04-29 for fiscal year ending 2022. Historical PLXP 10-K annual reports are available from 2010 through 2022.
Investors researching PLx Pharma Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
PLXP SEC Filings · 8 questionsPLx Pharma Inc. (PLXP) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 369 filings and access original documents at no cost. PLx Pharma Inc.'s CIK is 0001497504.